These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17885587)

  • 41. Special report: vaccines for the treatment of malignant melanoma.
    Tecnologica MAP Suppl; 2001 Apr; ():19-20. PubMed ID: 11718143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H; Joniau S; Van Gool SW
    Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
    Pashenkov M; Goëss G; Wagner C; Hörmann M; Jandl T; Moser A; Britten CM; Smolle J; Koller S; Mauch C; Tantcheva-Poor I; Grabbe S; Loquai C; Esser S; Franckson T; Schneeberger A; Haarmann C; Krieg AM; Stingl G; Wagner SN
    J Clin Oncol; 2006 Dec; 24(36):5716-24. PubMed ID: 17179105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanoma.
    Straatsma BR; Nusinowitz S; Young TA; Gordon LK; Chun MW; Rosen C; Seja E; Economou JS; Glaspy JA; Bozon V; Gomez-Navarro J; Ribas A
    Am J Ophthalmol; 2007 Jun; 143(6):958-969. PubMed ID: 17434437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy.
    Royer PJ; Bougras G; Ebstein F; Leveque L; Tanguy-Royer S; Simon T; Juge-Morineau N; Chevallier P; Harousseau JL; Gregoire M
    Exp Hematol; 2008 Mar; 36(3):329-39. PubMed ID: 18207305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial.
    Arai S; Meagher R; Swearingen M; Myint H; Rich E; Martinson J; Klingemann H
    Cytotherapy; 2008; 10(6):625-32. PubMed ID: 18836917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dendritic cell-based vaccines for pancreatic cancer and melanoma.
    Mulé JJ
    Ann N Y Acad Sci; 2009 Sep; 1174():33-40. PubMed ID: 19769734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment approaches for advanced cutaneous melanoma.
    Stein JA; Brownell I
    J Drugs Dermatol; 2008 Feb; 7(2):175-9. PubMed ID: 18335655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Xenovaccinotherapy for melanoma.
    Seledtsov VI; Shishkov AA; Surovtseva MA; Samarin DM; Seledtsova GV; Niza NA; Seledtsov DV
    Eur J Dermatol; 2006; 16(6):655-61. PubMed ID: 17229606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment.
    Dillman RO; McClay EF; Barth NM; Amatruda TT; Schwartzberg LS; Mahdavi K; de Leon C; Ellis RE; DePriest C
    Cancer Biother Radiopharm; 2015 Jun; 30(5):187-94. PubMed ID: 26083950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melanoma: is immunotherapy of benefit?
    Faries MB; Morton DL
    Adv Surg; 2003; 37():139-69. PubMed ID: 12953631
    [No Abstract]   [Full Text] [Related]  

  • 52. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
    Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y
    Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes.
    Lacreusette A; Lartigue A; Nguyen JM; Barbieux I; Pandolfino MC; Paris F; Khammari A; Dréno B; Jacques Y; Blanchard F; Godard A
    J Pathol; 2008 Dec; 216(4):451-9. PubMed ID: 18798220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient-specific dendritic-cell vaccines for metastatic melanoma.
    Dillman RO; Selvan SR; Schiltz PM
    N Engl J Med; 2006 Sep; 355(11):1179-81. PubMed ID: 16971731
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunotherapy for malignant melanoma--tracing Ariadne's thread through the labyrinth.
    Grange JM; Krone B; Stanford JL
    Eur J Cancer; 2009 Sep; 45(13):2266-73. PubMed ID: 19497734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The potential of exosomes in immunotherapy of cancer.
    Chaput N; Taïeb J; Schartz N; Flament C; Novault S; André F; Zitvogel L
    Blood Cells Mol Dis; 2005; 35(2):111-5. PubMed ID: 16027014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allogeneic and autologous melanoma vaccines: where have we been and where are we going?
    Sondak VK; Sabel MS; Mulé JJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2337s-2341s. PubMed ID: 16609055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The treatment of melanoma with an emphasis on immunotherapeutic strategies.
    Jack A; Boyes C; Aydin N; Alam K; Wallack M
    Surg Oncol; 2006 Jul; 15(1):13-24. PubMed ID: 16815006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma.
    Marshall JA; Forster TH; Purdie DM; Lanagan CM; O'Connor LE; O'Rourke MG; Johnson MK; See JL; Ellem KA; Martinez NR; López JA; Schmidt CW
    Immunol Cell Biol; 2006 Jun; 84(3):295-302. PubMed ID: 16681827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.